Company / Working Capital per Share
Dyne Therapeutics, Inc. Working Capital per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.03
FY2024
5-year range
$1.27 / $23.49
FY2020-FY2024
Trend
+373.5%
vs FY2023
Sector context
#95 of 212
Health Care
What the data says
Working Capital per Share changed +374% YoY in FY2024, a notable deviation from the 5-year average annual change of +111%.
Based on SEC 10-K filings.
6.03 in FY2024 with a 5-year CAGR of +3.5%.
Improved from $4.27 to $6.03 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -4.6%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
#95 of 212 in Health CareTop 45% of 212This company $6.03 Sector average $117.56
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 373.5% year-over-year.
- Ranks #95 out of 212 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.03 | +373.5% |
| FY2023 | $1.27 | -70.2% |
| FY2022 | $4.27 | -38.6% |
| FY2021 | $6.95 | -70.4% |
| FY2020 | $23.49 | +362.7% |
| FY2019 | $5.08 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026